New drug to fight multi-drug resistant TB soon in Uttar Pradesh
The new anti-TB drug, with delamanid as active substance, is currently administered to patients primarily children in the age group of six to 17 years in a few southern states of India and is yet to be introduced in Uttar Pradesh, which reported 4.22 lakh patients in 2018.
Jun 13, 2019, 12:09 PM ISTOver 15,000 fresh cases of TB detected: Health Minister JP Nadda
TB is an infectious, airborne disease that mainly affects the lungs. It is also one of the top ten causes of death worldwide.
Nov 17, 2017, 09:01 AM IST